Insulet Corp
(NAS:PODD)
$
263.23
-0.1 (-0.04%)
Market Cap: 18.46 Bil
Enterprise Value: 18.96 Bil
PE Ratio: 45.07
PB Ratio: 16.51
GF Score: 93/100 Insulet Corp at Piper Jaffray Healthcare Conference Transcript
Dec 04, 2019 / 02:00PM GMT
Release Date Price:
$182.89
(-0.62%)
Matthew Oliver O;Brien
Piper Jaffray Companies, Research Division - MD and Senior Research Analyst
' -
All right. We'll probably get started. Good morning, I'm Matt O'Brien, I cover medtech. We've got the Insulet team up next. Thanks so much for coming down and making it down. And I know there's a lot snowfall making it (inaudible) here. From the company we have Bret, who is the Chief (inaudible) Officer and (inaudible) Chief Financial Officer in the audience (inaudible) Deb and Michael. So we start on the third quarter. Outstanding (inaudible) on that. MDI patient population. We're estimating, just kind of guessing that you have about 70,000 MDI patients at this point. (inaudible) from the Omnipod. There's about 2.75
(technical difficulty)
Wayde D. McMillan
Insulet Corporation - Executive VP,CFO & Treasurer
Thank you.
Questions & Answers
Matthew Oliver O;Brien
Piper Jaffray Companies, Research Division - MD and Senior Research Analyst
' -
All right. So we're all
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot